Evidence map›Paper›PMID 31814888›Full record

ArticleAmerican journal of translational research2019

Unraveling the action mechanism of

Boyu Pan, Xiaona Shi, Tingting Ding, Liren Liu

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Endophytic Bacteria and Fungi Associated withPlants (Basel, Switzerland) · 2024
    Article
  3. Advances for pharmacological activities ofPharmaceutical biology · 2023
    Review
  4. Article
  5. Article
  6. Drug design, development and therapy · 2023
    Article
  7. Review
  8. Article
  9. Bioengineered · 2022
    Article
  10. Article
  11. Article
  12. Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
  13. Article
  14. Investigation of the Active Ingredients and Mechanism ofDrug design, development and therapy · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Boyu PanDepartment of Gastrointestinal Cancer Biology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer Tianjin 300060, China.
Xiaona ShiTianjin International Joint Academy of Biotechnology and Medicine Analytical Testing Center Tianjin 300457, China.
Tingting DingDepartment of Pathology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer Tianjin 300060, China.
Liren LiuDepartment of Gastrointestinal Cancer Biology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer Tianjin 300060, China.
Tianjin Medical University Cancer Institute and Hospital · CNTianjin International Joint Academy of Biomedicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a popular Chinese herbal medicine (CHM),

Indexed as

Chinese herb medicinenetwork pharmacologypolydatinPolygonum cuspidatum (Hu Zhang)UPLC-MS/MS

Identifiers

PMID31814888
PMCPMC6895524
OpenAlexW2997802807

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.